# Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients

> **NCT00311311** · PHASE3 · TERMINATED · sponsor: **Pfizer** · enrollment: 72 (actual)

## Conditions studied

- Atherosclerosis
- Kidney Failure

## Interventions

- **DRUG:** tacrolimus
- **DRUG:** mycophenolate mofetil
- **DRUG:** prednisone
- **DRUG:** sirolimus
- **DRUG:** tacrolimus
- **DRUG:** mycophenolate mofetil
- **DRUG:** prednisone

## Key facts

- **NCT ID:** NCT00311311
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-04
- **Primary completion:** 2010-12
- **Final completion:** 2012-01
- **Target enrollment:** 72 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2013-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00311311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00311311, "Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00311311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*